Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Women with non-classical congenital adrenal hyperplasia have higher levels of certain steroids, which can be reduced by treatment.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

PCOS women have more severe metabolic issues and higher androgen levels than hyperandrogenic women without PCOS.

More research is needed to understand if GLP-1 agonists affect hair health.

Hair glycation can indicate long-term blood sugar levels and diabetic nerve issues.

AHST shows promise for treating type 1 diabetes but needs more research before widespread use.

Women with androgenetic alopecia (AGA) are more insulin resistant than healthy women, with various insulin sensitivity indices being higher in the AGA group. An oral glucose tolerance test is suggested for women with AGA.

Hair analysis can reveal glucose levels in diabetic patients.

Taking thyroid medication reduced the patient's pituitary gland swelling and improved her symptoms.

Glucocorticoid treatment lowered androgen levels but didn't improve hirsutism or ovulation and caused weight gain.

HPLC may detect prediabetes and diabetes earlier than Immunoturbidimetry because it shows higher A1c levels.

Always consider xanthomatous hypophysitis before deciding on pituitary surgery.

Semaglutide helps obese PCOS patients lose weight and improve health.

Women with PCOS are more likely to have impaired glucose tolerance and type 2 diabetes, especially if they are Asian or obese.

Primary hypothyroidism can mimic pituitary failure but improves with hormone therapy.

GLP-1 receptor agonists may help or harm hair health, needing more research.

A low-glycemic diet improved hormone levels and well-being in overweight women with high androgen levels.

The man's symptoms improved and the tumor shrank after treatment with cabergoline.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

25% of premenopausal women with Type 1 diabetes have undiagnosed androgen excess disorders.

GLP-1 receptor agonists increase the risk of hair loss, mainly due to weight loss-related nutrient deficiency.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

Hair glycation can indicate long-term blood sugar trends in diabetics.

A man's adrenal insufficiency was caused by a pituitary tumor linked to kidney cancer.

High-dose glucocorticoid therapy clears skin lesions in pemphigus vulgaris but causes side effects like weight gain and muscle weakness.

GLP-1 receptor agonists increase the risk of hair loss, mainly due to nutrient deficiency from weight loss.

GLP-1 RAs help with diabetes and skin issues but can cause skin reactions and surgery challenges.

The woman's symptoms were due to an androgen-secreting tumor, not PCOS.

The woman's rare combination of diseases suggests an unknown factor may predispose individuals to multiple endocrine diseases.

The document concludes that HAIR-AN syndrome should be considered when a patient shows severe hyperandrogenism and insulin resistance after excluding tumors.